MIND News

DR. DOTY FEATURED IN HEALIO Q&A ON ADVANCING MULTIPLE SCLEROSIS CARE

Dr. Jonathan Doty, DO, neurologist at the Michigan Institute for Neurological Disorders (MIND), was recently featured in a Q&A with national digital medical news platform Healio discussing how advancements in multiple sclerosis (MS) treatment are shaping more personalized, proactive care.

In the interview, Dr. Doty highlights how the growing number of FDA-approved therapies, now more than 20, has transformed how specialists approach treatment decisions. He also emphasizes a shift toward earlier, more intensive treatment strategies, noting that MS can cause irreversible neurological damage early in the disease. Starting treatment sooner can help slow progression and preserve long-term function.

Dr. Doty discusses emerging therapies, including BTK inhibitors, which may offer more targeted options for progressive forms of MS, as well as the role of advanced diagnostics and biomarkers in improving disease monitoring.

Read the full Healio interview: https://www.healio.com/news/neurology/20260327/qa-expanding-therapy-earlier-treatment-inform-individualized-care-in-multiple-sclerosis